Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia ProjectThe Motley Fool • 01/14/21
Beigene Surges Closer To Breakout On $2.2 Billion Deal With NovartisInvestors Business Daily • 01/12/21
Novartis AG (NVS) CEO Vas Narasimham Presents at 39th Annual J.P. Morgan Virtual Healthcare Conference (Transcript)Seeking Alpha • 01/11/21
BeiGene Announces Collaboration with Novartis to Develop and Commercialize Anti-PD-1 Antibody TislelizumabBusiness Wire • 01/11/21
Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGeneGlobeNewsWire • 01/11/21
Novartis announces positive FDA Advisory Committee recommendation for use of Entresto® to treat patients with HFpEFGlobeNewsWire • 12/16/20
Novartis reports positive topline results from second Phase III trial of Beovu® in patients with diabetic macular edemaGlobeNewsWire • 12/15/20
Novartis provides update on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19GlobeNewsWire • 12/14/20
Novartis Kisqali® data demonstrate superior benefit across main intrinsic subtypes in metastatic breast cancerGlobeNewsWire • 12/09/20